載入...
Tetrathiomolybdate Protects against Bile Duct Ligation-Induced Cholestatic Liver Injury and Fibrosis
Tetrathiomolybdate (TM), a potent copper-chelating drug, was initially developed for the treatment of Wilson’s disease. Our working hypothesis is that the fibrotic pathway is copper-dependent. Because biliary excretion is the major pathway for copper elimination, a bile duct ligation (BDL) mouse mod...
Na minha lista:
| 發表在: | J Pharmacol Exp Ther |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2008
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4222180/ https://ncbi.nlm.nih.gov/pubmed/18299419 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.107.131227 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|